Cynosure, Inc. announced that it has received a medical device license issued by Health Canada to market MonaLisa Touch® for the treatment of symptoms related to Genitourinary Syndrome of Menopause (GSM),

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

Existing Users Log In